Recent investment activity

KANDO id: 562881

Corporate information

Funding rounds


Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Date Funding
EpimAb Biotherapeutics Biopharmaceutical company focused on bispecific antibodies. Series A

Current team

Past employees

Selected Products / Customers

Financials